ANGO vs MCK · rev $292.5M vs P/E 20, rev $403.43B
AngioDynamics Inc (ANGO) versus McKesson Corporation (MCK) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
ANGO currently screens at market cap $378.5M. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
Not investment advice. Open the ANGO and MCK stock pages for the full models.
Not investment advice.